Variant report

Variant	nsv7565
Chromosome Location	chr10:119167461-119212529
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1234)
CpG islands
(count:0)
Chromatin interactive
region (count:40)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1234 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:119170884-119171723	K562	blood:	n/a	n/a
2	ARID3A	chr10:119171119-119171670	HepG2	liver:	n/a	n/a
3	ARID3A	chr10:119202931-119203121	K562	blood:	n/a	n/a
4	ARID3A	chr10:119190709-119190971	K562	blood:	n/a	n/a
5	ARID3A	chr10:119173472-119173711	HepG2	liver:	n/a	n/a
6	ARID3A	chr10:119188081-119188360	K562	blood:	n/a	n/a
7	ARID3A	chr10:119168002-119168241	K562	blood:	n/a	n/a
8	ATF1	chr10:119167920-119168770	K562	blood:	n/a	n/a
9	ATF2	chr10:119202383-119202777	H1-hESC	embryonic stem cell:	n/a	n/a
10	ATF3	chr10:119188052-119188271	K562	blood:	n/a	n/a
11	BACH1	chr10:119202498-119202848	H1-hESC	embryonic stem cell:	n/a	n/a
12	BDP1	chr10:119188032-119188408	K562	blood:	n/a	n/a
13	BHLHE40	chr10:119202516-119203121	K562	blood:	n/a	chr10:119202516-119202532
14	BHLHE40	chr10:119184379-119184887	HepG2	liver:	n/a	n/a
15	BHLHE40	chr10:119184655-119184781	K562	blood:	n/a	n/a
16	BHLHE40	chr10:119167649-119169226	K562	blood:	n/a	n/a
17	BHLHE40	chr10:119188031-119188387	K562	blood:	n/a	n/a
18	BHLHE40	chr10:119172262-119172333	K562	blood:	n/a	n/a
19	BHLHE40	chr10:119190824-119190922	GM12878	blood:	n/a	n/a
20	BHLHE40	chr10:119209211-119209311	K562	blood:	n/a	n/a
21	BHLHE40	chr10:119202486-119202840	GM12878	blood:	n/a	chr10:119202516-119202532
22	BHLHE40	chr10:119170816-119171797	K562	blood:	n/a	n/a
23	BRCA1	chr10:119202482-119202746	H1-hESC	embryonic stem cell:	n/a	n/a
24	CBX3	chr10:119205509-119205849	K562	blood:	n/a	n/a
25	CBX3	chr10:119203094-119203458	K562	blood:	n/a	n/a
26	CBX3	chr10:119205547-119205718	K562	blood:	n/a	n/a
27	CBX3	chr10:119202385-119203048	K562	blood:	n/a	n/a
28	CBX3	chr10:119209182-119209443	K562	blood:	n/a	n/a
29	CBX3	chr10:119170883-119171574	K562	blood:	n/a	n/a
30	CCNT2	chr10:119170756-119171380	K562	blood:	n/a	n/a
31	CCNT2	chr10:119171696-119171903	K562	blood:	n/a	n/a
32	CCNT2	chr10:119188011-119188385	K562	blood:	n/a	n/a
33	CCNT2	chr10:119167913-119168900	K562	blood:	n/a	n/a
34	CEBPB	chr10:119202407-119202737	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr10:119173544-119173706	HepG2	liver:	n/a	n/a
36	CEBPB	chr10:119198908-119199172	MCF-7	breast:	n/a	chr10:119199018-119199029
37	CEBPB	chr10:119198896-119199157	A549	lung:	n/a	chr10:119199018-119199029
38	CEBPB	chr10:119173486-119173815	A549	lung:	n/a	n/a
39	CEBPB	chr10:119202369-119202719	K562	blood:	n/a	n/a
40	CEBPB	chr10:119198830-119199305	A549	lung:	n/a	chr10:119199018-119199029
41	CEBPB	chr10:119198900-119199184	K562	blood:	n/a	chr10:119199018-119199029
42	CEBPB	chr10:119198849-119199214	HepG2	liver:	n/a	chr10:119199018-119199029
43	CEBPB	chr10:119170917-119171715	K562	blood:	n/a	chr10:119171453-119171464
44	CEBPB	chr10:119198928-119199078	HepG2	liver:	n/a	chr10:119199018-119199029
45	CEBPB	chr10:119202411-119202810	IMR90	lung:	n/a	n/a
46	CEBPB	chr10:119198928-119199085	HepG2	liver:	n/a	chr10:119199018-119199029
47	CEBPB	chr10:119202450-119202761	HepG2	liver:	n/a	n/a
48	CEBPB	chr10:119173463-119174127	MCF-7	breast:	n/a	n/a
49	CEBPB	chr10:119202416-119202910	Hela-S3	cervix:	n/a	n/a
50	CEBPB	chr10:119198856-119199221	A549	lung:	n/a	chr10:119199018-119199029

No data

(count:40 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:119135318..119137458-chr10:119181859..119184416,2	K562	blood:
2	chr10:119196957..119199518-chr10:119202599..119205529,2	K562	blood:
3	chr10:119202108..119203037-chr10:119239554..119240472,4	MCF-7	breast:
4	chr10:119166797..119169829-chr10:119170083..119173543,3	K562	blood:
5	chr10:119165364..119168104-chr10:119178844..119180841,2	MCF-7	breast:
6	chr10:119170698..119175425-chr10:119187490..119191025,5	K562	blood:
7	chr10:119190789..119191423-chr10:119222057..119222562,2	K562	blood:
8	chr10:119172845..119175472-chr10:119177022..119179584,3	K562	blood:
9	chr10:119134136..119136901-chr10:119168830..119174034,7	K562	blood:
10	chr10:119170698..119175425-chr10:119187490..119191025,5	K562	blood:
11	chr10:119170265..119172396-chr10:119181469..119183550,3	K562	blood:
12	chr10:119202109..119203088-chr10:119256077..119256681,3	MCF-7	breast:
13	chr10:119162564..119164785-chr10:119169266..119172248,2	MCF-7	breast:
14	chr10:119129524..119131714-chr10:119168378..119170724,2	K562	blood:
15	chr10:119132403..119134513-chr10:119179179..119182109,2	K562	blood:
16	chr10:119175599..119177731-chr10:119180427..119183594,3	K562	blood:
17	chr10:119201211..119202926-chr10:119237979..119239662,2	MCF-7	breast:
18	chr10:119180932..119183329-chr10:119187493..119189672,2	K562	blood:
19	chr10:119166797..119169829-chr10:119170083..119173543,3	K562	blood:
20	chr10:119172477..119175424-chr10:119176927..119178901,2	MCF-7	breast:
21	chr10:119202081..119203340-chr10:119237533..119238326,4	MCF-7	breast:
22	chr10:118975993..118976717-chr10:119202046..119202670,2	K562	blood:
23	chr10:119152806..119155380-chr10:119168687..119171434,2	MCF-7	breast:
24	chr10:119176231..119179143-chr10:119180575..119182492,2	K562	blood:
25	chr10:119172477..119175424-chr10:119176927..119178901,2	MCF-7	breast:
26	chr10:119010108..119012234-chr10:119170394..119174212,3	K562	blood:
27	chr10:119172845..119175472-chr10:119177022..119179584,3	K562	blood:
28	chr10:119196957..119199518-chr10:119202599..119205529,2	K562	blood:
29	chr10:119010544..119012234-chr10:119170394..119173023,2	K562	blood:
30	chr10:119202301..119202866-chr10:119237850..119238472,2	MCF-7	breast:
31	chr10:119175599..119177731-chr10:119180427..119183594,3	K562	blood:
32	chr10:119095928..119098353-chr10:119180711..119183510,2	K562	blood:
33	chr10:119014556..119017412-chr10:119207820..119210608,2	K562	blood:
34	chr10:119202992..119204778-chr10:119219180..119221584,2	MCF-7	breast:
35	chr10:119190723..119191317-chr10:119237824..119238365,2	MCF-7	breast:
36	chr10:119176231..119179143-chr10:119180575..119182492,2	K562	blood:
37	chr10:119180932..119183329-chr10:119187493..119189672,2	K562	blood:
38	chr10:118975868..118977282-chr10:119208595..119209916,7	K562	blood:
39	chr10:119170265..119172396-chr10:119181469..119183550,3	K562	blood:
40	chr10:119165364..119168104-chr10:119178844..119180841,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-EMX2-1	chr10:119184705-119184863	ENSG00000258114.1
2	lnc-EMX2-1	chr10:119195727-119195835	ENSG00000258114.1

No data

Variant related genes	Relation type
ENSG00000258114	TF binding region
ENSG00000165650	chromatin interactions

Extended variants
information (count: 1857 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:1857 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562315768	chr10:119167472-119167473	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs529693655	chr10:119167490-119167491	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs543134162	chr10:119167494-119167495	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs562908676	chr10:119167498-119167499	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs11197989	chr10:119167502-119167503	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs137891504	chr10:119167528-119167529	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs565830577	chr10:119167533-119167534	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs192990856	chr10:119167622-119167623	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs541422876	chr10:119167650-119167651	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs548035178	chr10:119167666-119167667	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs114401669	chr10:119167717-119167718	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs116558274	chr10:119167735-119167736	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs7072493	chr10:119167736-119167737	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs570985979	chr10:119167762-119167763	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs142427535	chr10:119167795-119167796	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs553372211	chr10:119167809-119167810	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs7072734	chr10:119167857-119167858	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs542510992	chr10:119167864-119167865	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs11197991	chr10:119167902-119167903	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs575447160	chr10:119167945-119167946	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs182979124	chr10:119167979-119167980	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs563020572	chr10:119168001-119168002	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs532119566	chr10:119168057-119168058	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs145977326	chr10:119168102-119168103	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs532707252	chr10:119168106-119168107	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs139864025	chr10:119168112-119168113	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs1772807	chr10:119168146-119168147	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs548481501	chr10:119168163-119168164	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs149415155	chr10:119168165-119168166	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs566348191	chr10:119168166-119168167	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs186996221	chr10:119168167-119168168	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs550841676	chr10:119168207-119168208	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs570948903	chr10:119168235-119168236	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs536954138	chr10:119168240-119168241	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs539931635	chr10:119168241-119168242	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs546630424	chr10:119168253-119168254	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs566878461	chr10:119168269-119168270	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs377567144	chr10:119168401-119168402	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs535738081	chr10:119168402-119168403	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs555622935	chr10:119168405-119168406	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs112401919	chr10:119168445-119168446	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs538043532	chr10:119168447-119168448	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs200745460	chr10:119168456-119168457	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs557941975	chr10:119168635-119168636	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs576819381	chr10:119168662-119168663	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs28653245	chr10:119168668-119168669	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs559053090	chr10:119168682-119168683	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs145671578	chr10:119168684-119168685	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs375429638	chr10:119168706-119168707	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs541876458	chr10:119168707-119168708	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Paraganglioma	17535989	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
T-cell lymphomas	19863542	CNVD
Breast cancer	16397240	CNVD
Urothelial carcinoma	21177765	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Hepatocellular carcinoma	16750200	CNVD
Barrett''s syndrome	19417022	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	21364760	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Sezary syndrome	18413736	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Apert syndrome	21572526	CNVD
Macular degeneration	22558131	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Muscular dystrophy	21149563	CNVD
Honadal dysgenesis	21048976	CNVD
Glioma	18556773	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:503 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:119160000-119172400	Enhancers	Primary neutrophils fromperipheralblood	blood
2	chr10:119164400-119170200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr10:119164600-119170200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr10:119164800-119167800	Weak transcription	Monocytes-CD14+_RO01746	blood
5	chr10:119164800-119173400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr10:119165000-119167600	Weak transcription	Primary monocytes fromperipheralblood	blood
7	chr10:119165200-119167600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
8	chr10:119165200-119170400	Weak transcription	Duodenum Mucosa	Duodenum
9	chr10:119165800-119170200	Weak transcription	Liver	Liver
10	chr10:119166200-119167800	Enhancers	K562	blood
11	chr10:119166200-119173800	Enhancers	Primary hematopoietic stem cells	blood
12	chr10:119166600-119169600	Weak transcription	HepG2	liver
13	chr10:119167200-119167600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
14	chr10:119167600-119168800	Enhancers	Primary monocytes fromperipheralblood	blood
15	chr10:119167600-119171400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr10:119167600-119172200	Enhancers	Primary hematopoietic stem cells short term culture	blood
17	chr10:119167800-119168000	Enhancers	Primary B cells from cord blood	blood
18	chr10:119167800-119168800	Enhancers	Monocytes-CD14+_RO01746	blood
19	chr10:119167800-119169400	Flanking Active TSS	K562	blood
20	chr10:119168000-119168600	Enhancers	Esophagus	oesophagus
21	chr10:119168400-119168800	Enhancers	Lung	lung
22	chr10:119168400-119169600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr10:119168400-119170400	Enhancers	Spleen	Spleen
24	chr10:119168600-119171600	Weak transcription	Esophagus	oesophagus
25	chr10:119168800-119169000	Weak transcription	Lung	lung
26	chr10:119168800-119169800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
27	chr10:119169000-119169400	Enhancers	Lung	lung
28	chr10:119169000-119170000	Enhancers	NHEK	skin
29	chr10:119169200-119169400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr10:119169200-119169800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr10:119169200-119169800	Enhancers	HMEC	breast
32	chr10:119169400-119169600	Enhancers	Breast Myoepithelial Primary Cells	Breast
33	chr10:119169400-119171400	Enhancers	K562	blood
34	chr10:119169400-119172200	Weak transcription	Lung	lung
35	chr10:119169600-119171000	Enhancers	HepG2	liver
36	chr10:119169600-119173200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr10:119169800-119173400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr10:119169800-119173400	Weak transcription	HMEC	breast
39	chr10:119169800-119173600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr10:119170000-119173600	Weak transcription	NHEK	skin
41	chr10:119170200-119170400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr10:119170200-119171600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
43	chr10:119170200-119171800	Enhancers	Liver	Liver
44	chr10:119170400-119170600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr10:119170400-119171600	Enhancers	Duodenum Mucosa	Duodenum
46	chr10:119170400-119171600	Weak transcription	Spleen	Spleen
47	chr10:119170600-119170800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr10:119170600-119171200	Enhancers	Fetal Heart	heart
49	chr10:119170800-119171600	Enhancers	Fetal Intestine Small	intestine
50	chr10:119170800-119174400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links